DNA vs. WBA

In the year-to-date period, DNA achieves a -87.00% return, which is significantly lower than WBA's -59.81% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Walgreens Boots Alliance, Inc. (WBA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DNA Sharpe Ratio is -0.84, which is comparable to the WBA Sharpe Ratio of -1.10. The chart below compares the historical Sharpe Ratios of DNA and WBA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DNA has not paid dividends to shareholders, while WBA's dividend yield for the trailing twelve months is around 10.31%.

The maximum DNA drawdown since its inception was -99.10%, which is greater than WBA's maximum drawdown of -87.93%. Use the drawdown chart below to compare losses from any high point for DNA and WBA. For additional features, visit the drawdowns tool.

Ginkgo Bioworks Holdings, Inc. (DNA) has a higher volatility of 33.43% compared to Walgreens Boots Alliance, Inc. (WBA) at 22.16%. This indicates that DNA's price experiences larger fluctuations and is considered to be riskier than WBA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Walgreens Boots Alliance, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.